gvtcx

Dose Banded and Patient Specific Doses of Systemic Anti-Cancer Treatments (SACT)

Barts Health NHS Trust Published 2 May 2019 Contracts Finder

key details

Value£6,000,000
Statuscomplete
Category (CPV) 85149000
Deadline10 Jun 2019
Contract start1 Sept 2019
Contract end31 Aug 2024
Procedureopen
SME suitableNo
OCIDocds-b5fd17-7cf13c70-f7f2-4a59-943d-39c67599aa2e

Award

SupplierValueDateStatus
No Award was made £6,000,000 10 Jun 2019 active

description

The Trust is the cancer centre for North East London and provides a medical and haematological oncology service including bone marrow transplantation. The chemotherapy pharmacy department has a licensed chemotherapy production unit, providing over 45,000 doses of systemic anti-cancer treatments (SACT) per year.

Demand for the provision of SACT has been rising consistently year on year. As such the department has developed a strategy to meet this demand and ensure that patient treatment requirements can be met. This strategy includes maximising efficiency of our existing production capacity by outsourcing doses that can be manufactured externally, to quality standards and that will be safe for the patient.

The outsourced doses will be purchased in the form of both readymade dose banded products and patient specific doses.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
11 Jun 2019 Award (award) · 93e4d86a-df48-4c53-9807-3fe324c108cf-294465

more from Barts Health NHS Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.